X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16862) 16862
Book Chapter (251) 251
Newsletter (67) 67
Magazine Article (28) 28
Publication (20) 20
Book / eBook (12) 12
Dissertation (6) 6
Web Resource (5) 5
Newspaper Article (4) 4
Reference (4) 4
Conference Proceeding (3) 3
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12175) 12175
science & technology (12065) 12065
life sciences & biomedicine (11591) 11591
male (7269) 7269
angiotensin-converting enzyme inhibitors - therapeutic use (6261) 6261
female (5411) 5411
animals (5169) 5169
cardiovascular system & cardiology (4275) 4275
hypertension - drug therapy (4213) 4213
angiotensin (4198) 4198
hypertension (3972) 3972
middle aged (3882) 3882
aged (3549) 3549
antihypertensive agents - therapeutic use (3534) 3534
pharmacology & pharmacy (2799) 2799
cardiac & cardiovascular systems (2595) 2595
blood pressure - drug effects (2454) 2454
angiotensin ii type 1 receptor blockers - therapeutic use (2435) 2435
angiotensin receptor antagonists (2414) 2414
treatment outcome (2329) 2329
rats (2309) 2309
renin-angiotensin system - drug effects (2299) 2299
adrenergic beta-antagonists - therapeutic use (2168) 2168
heart failure (2161) 2161
adult (2160) 2160
angiotensin receptor antagonists - therapeutic use (2080) 2080
heart failure - drug therapy (2037) 2037
peripheral vascular disease (2002) 2002
angiotensin ii (1936) 1936
risk factors (1888) 1888
tetrazoles - therapeutic use (1843) 1843
drug therapy, combination (1829) 1829
blood pressure (1760) 1760
abridged index medicus (1683) 1683
hypertension - physiopathology (1582) 1582
drug therapy (1540) 1540
medicine & public health (1512) 1512
enzymes (1359) 1359
renin-angiotensin system (1343) 1343
general & internal medicine (1294) 1294
angiotensin-converting enzyme inhibitors - pharmacology (1286) 1286
medicine, general & internal (1224) 1224
diabetes (1195) 1195
research (1191) 1191
care and treatment (1180) 1180
calcium channel blockers - therapeutic use (1157) 1157
ace inhibitors (1149) 1149
analysis (1144) 1144
renin-angiotensin system - physiology (1127) 1127
hypertension - complications (1091) 1091
cardiology (1089) 1089
losartan - therapeutic use (1089) 1089
aged, 80 and over (1078) 1078
urology & nephrology (1055) 1055
mice (1029) 1029
diuretics - therapeutic use (1025) 1025
health aspects (1013) 1013
mortality (1013) 1013
antihypertensive agents - pharmacology (1010) 1010
internal medicine (959) 959
angiotensin ii type 1 receptor blockers - pharmacology (958) 958
time factors (947) 947
heart failure - physiopathology (918) 918
medicine (913) 913
benzimidazoles - therapeutic use (909) 909
rodents (899) 899
double-blind method (892) 892
randomized controlled trials as topic (892) 892
disease models, animal (867) 867
mineralocorticoid receptor antagonists - therapeutic use (858) 858
physiology (854) 854
rats, sprague-dawley (845) 845
angiotensin-converting enzyme inhibitors - adverse effects (832) 832
dose-response relationship, drug (825) 825
angiotensin-converting enzyme inhibitors (804) 804
losartan (787) 787
cardiovascular diseases (782) 782
physiological aspects (765) 765
renin (761) 761
clinical trials as topic (760) 760
cardiovascular disease (758) 758
prospective studies (757) 757
tetrazoles - pharmacology (755) 755
cardiovascular (750) 750
retrospective studies (750) 750
antihypertensive agents - adverse effects (721) 721
biphenyl compounds - therapeutic use (710) 710
valsartan (692) 692
diuretics (684) 684
aldosterone (682) 682
follow-up studies (667) 667
enzyme inhibitors (665) 665
research article (659) 659
angiotensin ii - pharmacology (649) 649
angiotensin ii - metabolism (648) 648
angiotensin-converting enzyme inhibitors - administration & dosage (639) 639
disease progression (637) 637
inflammation (627) 627
kidney diseases (621) 621
oxidative stress (610) 610
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16549) 16549
German (253) 253
Japanese (232) 232
French (116) 116
Russian (91) 91
Spanish (82) 82
Italian (56) 56
Chinese (43) 43
Portuguese (35) 35
Hungarian (28) 28
Polish (24) 24
Danish (19) 19
Czech (15) 15
Swedish (12) 12
Dutch (11) 11
Turkish (10) 10
Ukrainian (10) 10
Norwegian (8) 8
Finnish (6) 6
Hebrew (4) 4
Croatian (3) 3
Lithuanian (3) 3
Korean (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 01/2015, Volume 372, Issue 3, pp. 211 - 221
Journal Article
European journal of heart failure, ISSN 1388-9842, 07/2014, Volume 16, Issue 7, pp. 817 - 825
Journal Article
European journal of heart failure, ISSN 1388-9842, 10/2013, Volume 15, Issue 10, pp. 1173 - 1184
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2014, Volume 63, Issue 12, pp. 1123 - 1133
Heart failure is a global pandemic affecting an estimated 26 million people worldwide and resulting in more than 1 million hospitalizations annually in both... 
acute | heart failure | registry | hospitalization | inpatient | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Age Distribution | Vasodilator Agents - therapeutic use | Anemia - epidemiology | United States | Humans | Catheterization, Swan-Ganz - utilization | Male | Dyspnea - etiology | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Electrocardiography | Female | Registries | Coronary Angiography - utilization | Heart Failure - diagnosis | Heart Failure - epidemiology | Heart Failure - etiology | Drug Utilization - statistics & numerical data | Length of Stay - statistics & numerical data | Adrenergic beta-Antagonists - therapeutic use | Hyponatremia - epidemiology | Cardiac Resynchronization Therapy - utilization | Echocardiography | Glomerular Filtration Rate | Hospital Mortality | Comorbidity | Europe | Defibrillators, Implantable - utilization | Hospitalization | Evidence-Based Medicine | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Quality Improvement | Asia | Natriuretic Peptides - analysis | Sex Distribution | Diuretics - therapeutic use | Aged | Angiotensin Receptor Antagonists - therapeutic use | Heart failure | Medical colleges | Medical research | Mortality | Therapeutics | Economic aspects | Medicine, Experimental | Natriuretic peptides | Homeopathy | Materia medica and therapeutics | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2014, Volume 371, Issue 11, pp. 993 - 1004
The angiotensin receptor–neprilysin inhibitor LCZ696 was compared with the ACE inhibitor enalapril in patients with advanced heart failure... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Humans | Middle Aged | Kaplan-Meier Estimate | Aminobutyrates - adverse effects | Hospitalization - statistics & numerical data | Male | Aminobutyrates - therapeutic use | Enalapril - therapeutic use | Enalapril - adverse effects | Heart Failure - drug therapy | Stroke Volume | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Neprilysin - antagonists & inhibitors | Female | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Angiotensin Receptor Antagonists - adverse effects | Heart Failure - mortality | Heart failure | Enalapril | Patient outcomes | Angiotensin | Enalaprilat | Dosage and administration | Research | Drug therapy | Enzymes | Statistical analysis | Mortality | Angioedema | Hypotension | Cough | Studies | Hyperkalemia | Death | Neprilysin | Heart diseases | Index Medicus | Abridged Index Medicus | MORTALITY | SURVIVAL | RANDOMIZED-TRIAL | RECEPTOR | Klinisk medicin | NEUTRAL ENDOPEPTIDASE INHIBITION | NATRIURETIC-PEPTIDE | Medicine | Clinical Medicine | CONVERTING ENZYME-INHIBITION | MORBIDITY | EJECTION FRACTION | General & Internal | DOUBLE-BLIND
Journal Article
Journal of neuroinflammation, ISSN 1742-2094, 02/2012, Volume 9, Issue 1, pp. 38 - 38
Background: Several recent studies have shown that angiotensin type 1 receptor (AT1) antagonists such as candesartan inhibit the microglial inflammatory response and dopaminergic cell loss in animal models of Parkinson's disease... 
Neuroprotection | Peroxisome proliferator-activated receptor gamma | Angiotensin | Neuroinflammation | AT1 | Parkinson | Microglia | Telmisartan | Neurosciences | Immunology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Encephalitis - prevention & control | Microglia - metabolism | Tyrosine 3-Monooxygenase - metabolism | Benzoates - therapeutic use | Leukocyte Common Antigens - metabolism | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Male | PPAR gamma - metabolism | Brain - metabolism | MPTP Poisoning - complications | Mass Spectrometry | Dopaminergic Neurons - drug effects | Cell Death - drug effects | Benzimidazoles - therapeutic use | Disease Models, Animal | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology | Microglia - drug effects | Gene Expression Regulation - genetics | Mice, Inbred C57BL | Encephalitis - pathology | Mice, Knockout | Brain - drug effects | Gene Expression Regulation - drug effects | Animals | PPAR gamma - antagonists & inhibitors | Analysis of Variance | Anilides - pharmacology | Brain - pathology | Lectins | Mice | MPTP Poisoning - chemically induced | Encephalitis - etiology | Receptor, Angiotensin, Type 1 - deficiency | Index Medicus | neuroinflammation | telmisartan | neuroprotection | microglia | peroxisome proliferator-activated receptor gamma
Journal Article